[Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis].

[Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis].

Bibliographic Details
Main Author:	Brunner, T
Format:	Journal article
Language:	German
Published:	2012

Similar Items

Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis | Gemcitabin-basierte Strahlenchemotherapie beim lokal fortgeschrittenen Pankreaskarzinom - eine Metaanalyse
by: Brunner, T
Published: (2012)

Gemcitabine-based chemoradiotherapy in locally advanced pancreas carcinoma - A meta-analysis
by: Brunner, T
Published: (2012)

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients.
by: Brunner, T, et al.
Published: (2011)

The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer
by: Ryoji Takada, et al.
Published: (2021-09-01)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
by: Mukherjee, S, et al.
Published: (2013)

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
by: Ma Yue, et al.
Published: (2011-03-01)

Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines
by: Waisse Waissi, et al.
Published: (2021-06-01)

Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis.
by: Zu-Yao Yang, et al.
Published: (2013-01-01)

Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
by: Shouki Bazarbashi, et al.
Published: (2022-05-01)

Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
by: Wang Y, et al.
Published: (2016-06-01)

Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study
by: Takamichi Igarashi, et al.
Published: (2023-01-01)

Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer
by: Victor H. F. de Jesus, et al.
Published: (2020-02-01)

Impact of chemoradiotherapy on the survival of unresectable locally advanced pancreatic cancer: a retrospective cohort analysis
by: Zi-Meng Wang, et al.
Published: (2023-04-01)

Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis
by: Marko Damm, et al.
Published: (2021-08-01)

Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01)

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy
by: Xiaofei Zhu, et al.
Published: (2021-06-01)

Consolidative Chemoradiotherapy After Induced Chemotherapy Is an Optimal Regimen for Locally Advanced Pancreatic Cancer
by: Lili Wu, et al.
Published: (2020-01-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01)

Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
by: Nicolas Williet, et al.
Published: (2021-06-01)

Correlation of 18F-fluorodeoxyglucose positron emission tomography parameters with patterns of disease progression in locally advanced pancreatic cancer after definitive chemoradiotherapy
by: Wilson, J, et al.
Published: (2017)

Is neoadjuvant chemoradiotherapy for pancreatic cancer beneficial: A systematic review and meta-analysis
by: Wenhao Luo, et al.
Published: (2022-11-01)

Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
by: Neoptolemos John P, et al.
Published: (2008-07-01)

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
by: Holyoake, DLP, et al.
Published: (2018)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
by: Holyoake, D, et al.
Published: (2016)

Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials.
by: Qin Li, et al.
Published: (2014-01-01)

Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis
by: Haonan Liu, et al.
Published: (2022-12-01)

Chemoradiotherapy in the treatment of locally advanced cervical cancer
by: Lina Daukantienė, et al.
Published: (2013-01-01)

Preoperative chemoradiotherapy for locally advanced gastric cancer
by: Pepek Joseph M, et al.
Published: (2013-01-01)

Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone
by: Hua Chen, et al.
Published: (2018-10-01)

Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-Analysis
by: Gaëtan Des Guetz, et al.
Published: (2021-11-01)

Efficacy of chemotherapy versus chemoradiotherapy for locally advanced endometrial cancer: a systematic review and meta‐analysis
by: Xiaoyong Xiang, et al.
Published: (2021-03-01)

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
by: Wilson, J, et al.
Published: (2017)

Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.
by: Gustav J Ullenhag, et al.
Published: (2017-01-01)

Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study
by: Alessandro Passardi, et al.
Published: (2019-05-01)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
by: Kamalika Samanta, et al.
Published: (2019-11-01)

Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer
by: Jiayuan Chen, et al.
Published: (2021-07-01)

Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis
by: Zhou Ma, et al.
Published: (2022-08-01)

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis
by: Francesca De Felice, et al.
Published: (2017-05-01)

Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis
by: Young Seob Shin, et al.
Published: (2022-02-01)